For more than 25 years, Biomedical Development Corporation has been bringing commercially-viable products to market by linking promising technologies with vital sources of research funding. By connecting breakthrough technologies with the right expertise, BDC has secured more than 60 SBIR/STTR grant awards from the National Institutes of Health and other sources.

BDC's capital-efficient development model utilizes non-dilutive government funding to demonstrate the safety of new products and prove the feasibility of high-risk technologies. The BDC model has a long history of success, combining rigorous and systematic processes with an accomplished staff, supported by essential laboratory and manufacturing facilities to accelerate technology transfer and commercialization.

Skill Sets, Competencies, and Know-How:
Grant Writing: 60+ funded NIH SBIR/STTR grants
Clinical Trials: 20+ clinical studies completed under Good Clinical Practices
Regulatory: IND and 510(k) filings
Manufacturing: Quality systems and current Good Manufacturing Practices
Formulation Development: From the bench to manufacturing

View funded BDC projects on the NIH Website: Type 'Biomedical Development Corporation' in the Institute Block and select multiple years.